Welcome to LookChem.com Sign In|Join Free
  • or
1-(2-Bromothiazol-4-yl)ethanone is a chemical compound characterized by the molecular formula C6H5BrNOS. It presents as a yellow to brown crystalline solid, known for its strong, pungent odor. 1-(2-broMothiazol-4-yl)ethanone is utilized in the realms of organic synthesis and chemical research, contributing to the development of various chemical products and understanding of chemical reactions.

128979-09-9

Post Buying Request

128979-09-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128979-09-9 Usage

Uses

Used in Organic Synthesis:
1-(2-Bromothiazol-4-yl)ethanone is used as a key intermediate in the synthesis of various organic compounds. Its unique structure allows for the creation of a wide range of products, making it a valuable asset in the field of organic chemistry.
Used in Chemical Research:
In the context of chemical research, 1-(2-Bromothiazol-4-yl)ethanone serves as a crucial compound for studying and understanding specific chemical reactions and mechanisms. Its application aids in the advancement of knowledge within the chemical sciences.
Used in Pharmaceutical Industry:
Although not explicitly mentioned in the provided materials, given its structural complexity and use in organic synthesis, 1-(2-Bromothiazol-4-yl)ethanone may also find applications in the pharmaceutical industry. It could potentially be used as a building block for the development of new drugs or drug candidates, targeting specific medical conditions.
Safety Precautions:

Check Digit Verification of cas no

The CAS Registry Mumber 128979-09-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,9,7 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 128979-09:
(8*1)+(7*2)+(6*8)+(5*9)+(4*7)+(3*9)+(2*0)+(1*9)=179
179 % 10 = 9
So 128979-09-9 is a valid CAS Registry Number.

128979-09-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-Bromo-1,3-thiazol-4-yl)ethanone

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128979-09-9 SDS

128979-09-9Downstream Products

128979-09-9Relevant academic research and scientific papers

Optimization of Novel 1-Methyl-1 H-Pyrazole-5-carboxamides Leads to High Potency Larval Development Inhibitors of the Barber's Pole Worm

Le, Thuy G.,Kundu, Abhijit,Ghoshal, Atanu,Nguyen, Nghi H.,Preston, Sarah,Jiao, Yaqing,Ruan, Banfeng,Xue, Lian,Huang, Fei,Keiser, Jennifer,Hofmann, Andreas,Chang, Bill C. H.,Garcia-Bustos, Jose,Jabbar, Abdul,Wells, Timothy N. C.,Palmer, Michael J.,Gasser, Robin B.,Baell, Jonathan B.

, p. 10875 - 10894 (2019/01/04)

A phenotypic screen of a diverse library of small molecules for inhibition of the development of larvae of the parasitic nematode Haemonchus contortus led to the identification of a 1-methyl-1H-pyrazole-5-carboxamide derivative with an IC50 of 0.29 μM. Medicinal chemistry optimization targeted modifications on the left-hand side (LHS), middle section, and right-hand side (RHS) of the scaffold in order to elucidate the structure-activity relationship (SAR). Strong SAR allowed for the iterative and directed assembly of a focus set of 64 analogues, from which compound 60 was identified as the most potent compound, inhibiting the development of the fourth larval (L4) stage with an IC50 of 0.01 μM. In contrast, only 18% inhibition of the mammary epithelial cell line MCF10A viability was observed, even at concentrations as high as 50 μM.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

-

Paragraph 1235, (2015/02/18)

Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

-

Page/Page column 270; 271, (2015/02/02)

Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 128979-09-9